Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial

Clinical trial NCT04743687 · UNKNOWN

Trial details

NCT number: NCT04743687
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Multicentric Castleman's Disease

Start date: 2021-01-01
Primary completion: 2025-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.